title: Haemorrhagic complications associated with reduced alpha2-plasmin inhibitor during imatinib use in a patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia.
authors.forename: Kosei
authors.initials: K
authors.lastname: Matsue
authors.forename: Takatoshi
authors.initials: T
authors.lastname: Aoki
authors.forename: Jun
authors.initials: J
authors.lastname: Odawara
authors.forename: Shun-ichi
authors.initials: S
authors.lastname: Kimura
authors.forename: Masayuki
authors.initials: M
authors.lastname: Yamakura
authors.forename: Masami
authors.initials: M
authors.lastname: Takeuchi
mesh_terms: D000368:Aged; D000933:Antifibrinolytic Agents / Q000097:blood*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D006471:Gastrointestinal Hemorrhage / Q000097:blood / Q000139:chemically induced*; D006801:Humans; D000068877:Imatinib Mesylate; D008297:Male; D010677:Philadelphia Chromosome; D010879:Piperazines / Q000627:therapeutic use*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D011743:Pyrimidines / Q000627:therapeutic use*
chemical_list: D000933:Antifibrinolytic Agents; D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate